The Food and Drug Administration will award a $1 million grant to take EHR data and continuously analyze the risks and benefits of drugs once they hit the market, according to Clinical Innovation + Technology.
The grant will be awarded for the development of analytic processes that can mine hundreds of millions of patient records and identify drug safety trends. Applications are due June 15 and the grant will be awarded July 15.
More articles on health IT:
CoverMyMeds and NewCrop launch first complete ePA solution
Rite Aid to enter retail health sphere, hires CIO
7 tips to avoid an ICD-10 operations bottleneck